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Many nanoscale materials have been developed to investigate the eﬀects on stem cell
diﬀerentiations via topographical and chemical cues for applications in tissue engineering and
regenerative medicine. The use of plant viruses as cell supporting substrates has been of particular
interest due to the rapid induction of bone marrow derived mesenchymal stem cells (BMSCs)
towards osteogenic cells. In this study, the role of Tobacco mosaic virus (TMV) and its early
eﬀects on osteoinduction with particular emphasis on the regulation of bone morphogenetic
protein-2 (BMP2) was examined. We observed that the cells on the virus substrate immediately
aggregated and formed bone-like nodules within 24 hours. An immediate increase in BMP2 gene
and protein expression for cells on the TMV substrate was observed within 8 hours of
osteoinduction. Moreover, BMP2 expression was highly localized to cells within the cell
aggregates. This enhanced diﬀerentiation only occurred when TMV was coated on a solid support
but not upon adding the virus to the media solution. Taken together, the results from this study
highlight the potential of virus-based nanomaterials to promote endogenous BMP2 production
which may prove to be a unique approach to studying the regulatory mechanisms involved in
early osteoblastic diﬀerentiation.
Introduction
Stem cell fate is dependent on the surrounding stimuli, including
both soluble and insoluble factors. How stem cells respond to
diﬀerent nanoscale cues has been extensively studied for tissue
engineering and regenerative medicine applications.1 There are
several reports indicating that stem cell diﬀerentiation can be
dictated at the nanometre level.2,3 Bone marrow derived
mesenchymal stem cells (BMSCs) are from the non-hematopoietic
sub-population of bone marrow stroma,4,5 which have the
ability to self-renew and diﬀerentiate to various lineages, such
as adipocytes, osteocytes, chondrocytes, hepatocytes, neurons,
muscle cells, and epithelial cells.5,6 The pluripotent potential
of BMSCs, ease of isolation, rapid expansion,7 and less
controversial use than embryonic stem cells make this cell type
an ideal source of adult stem cells to study material-mediated
diﬀerentiation.
Recently, we have reported accelerated osteogenic diﬀeren-
tiation of BMSCs grown on plant virus coated substrates in
comparison to cells cultured on conventional tissue culture
plastic (TCP).8,9 Two diﬀerent plant viruses were employed in
those studies, i.e. spherical Turnip yellow mosaic virus (TYMV)
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Insight, innovation, integration
Bone morphogenetic protein-2 (BMP2) is a potent growth
factor that is supplemented to induce bone diﬀerentiation in
many conventional tissue diﬀerentiation studies. Here, we
report that by using plant virus as a biocompatible nano-
material, endogenous expression of BMP2 can be induced in
mesenchymal stem cells to direct diﬀerentiation towards
osteoblasts. This enhanced diﬀerentiation only occurs when
virus is coated on a solid support but not with the addition of
virus as a solution to the media. Therefore, the possibility of
such nanomaterials that increase endogenous BMP2 produc-
tion is highly relevant for BMP2 mediated stem cell diﬀer-
entiation and future bone replacement therapies.
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and rod-like Tobacco mosaic virus (TMV). In both situations,
several key mRNA markers associated with bone diﬀerentiation
peaked at day 14 for cells on virus-coated substrates, whereas the
cells on conventional plates required additional 7 days to reach
similar expression proﬁles.8,9 Moreover, immunohistochemical
staining for osteoblastic speciﬁc diﬀerentiationmarkers, osteocalcin,
osteonectin, and osteopontin, had supported the gene expression
proﬁles on day 14. The expressions of such osteogenic markers
were further enhanced upon chemically modifying the virus
with phosphates as indicated by increased Ca2+ mineralization
and even higher mRNA expression levels of osteocalcin.10 More
importantly, gene proﬁle studies of total mRNA and real time
PCR suggested an early upregulation of endogenous mRNA
levels of bone morphogenetic protein-2 (BMP2). This increase
in the BMP2mRNA level was observed for BMSCs cultured on
TMV substrates within 24 hours of osteoinduction, which we
speculate may be a key factor in the enhanced diﬀerentiation of
BMSCs on virus coated substrates.8
BMP2 is a member of the bone morphogenetic protein
subgroup within the transforming growth factor b (TGF-b)
super family. Among the bone morphogenetic proteins
(BMPs), the role of BMP2 in osteoblast diﬀerentiation and
bone formation during embryonic skeletal development and
postnatal bone remodelling has been extensively investigated.11
Animal studies have shown that BMP2 mRNA expression was
at the maximal level within 24 hours of murine fracture injury,
indicating that BMP2 is highly involved in bone repair initiation.12
The results from another study showed that BMP2, BMP6, and
BMP9 were potent inducers of mesenchymal stem cell diﬀerentia-
tion towards osteoblasts.13 Recombinant human BMP2 (rhBMP2)
is commercially available and used as a therapeutic supplement for
bone repair in spine fusion surgeries and tibial fracture healing.14
The supplement can promote faster bone fusion for patients with
back pain by promoting bone formation in vivo, and many
hydrogel encapsulation studies have shown enhanced osteogenic
diﬀerentiation of MSCs in vitro.15 However, rhBMP2 is costly
and some recent studies reported the adverse eﬀects caused by
implant failure or leakage causing life-threatening urogenital
events, retrograde ejaculation, back and leg pain, hematoma,
or breathing diﬃculty.16 Therefore, the use of nanoscale
materials to promote endogenous BMP2 production becomes
an extremely attractive route for studying the mechanisms
involved in bone tissue repair. This report is to examine the virus-
based system and its role in early diﬀerentiation of BMSCs by
monitoring its ability to upregulate BMP2 expression.
TMV is a rod-shaped particle measuring 300 nm in length
with a diameter of 18 nm. The shape of the plant virus
resembles the size scales of ﬁbrillar extracellular matrix
(ECM) protein, such as collagen. The viral capsid consists of
2130 identical coat protein subunits assembled in a helical
structure around the single stranded genomic RNA. The
production of TMV is cost eﬀective and the resulting viral
particles are highly uniform in size. The ability of TMV to be
easily and uniformly manipulated via chemical10,17 and genetic
modiﬁcations18 has gained traction as novel biomaterials
for potential tissue engineering applications.19,20 Herein, we report
the early molecular events that occur within the ﬁrst 24 hours
of osteoinduction in BMSCs when cultured on TMV-coated
substrates. The results indicate that BMP2 mRNA expression
is dramatically increased within 8 hours of osteoinduction and
protein expression was found to be highly localized to the
cell clumps. The virus coating provided a signiﬁcant increase
in BMP2 mRNA levels in comparison to dexamethasone
treatment alone. However, the addition of dexamethasone in
the presence of the virus provided the greatest enhancement in
BMP2 gene expression. The results from QCM-D and TMV
supplemented cultures suggest that dexamethasone and TMV
act independently on BMP2 expression. Extended analyses
with cytokine arrays showed that diﬀerent cytokines were
present in the conditioned media from cells cultured on
TMV-coated substrates; however, these cytokines have not
previously been associated with early osteogenic diﬀerentiation.
Alternatively, actin polymerization appeared to be congruent
with the recent report associating actin depolymerisation and
mineralization.25 The results reported in this study clearly
support the role of TMV coated substrates acting synergistically
with dexamethasone to regulate early BMP2 expression and
ultimately enhance stem cell diﬀerentiation.
Results and discussion
The morphological diﬀerences of BMSCs on TCP versus TMV
substrates
The morphological diﬀerences of BMSCs cultured on TCP or
TMV coated substrates (e.g. 3-aminopropyltriethoxysilane
(APTES) grafted coverslips) were imaged at the early time
points. After 6 hours in basal media, cells on TCP fully spread
on the substrate (Fig. 1A), whereas cells seeded on TMV
wafers partially spread (Fig. 1D). 24 Hours after seeding,
BMSCs on the TCP sample continued to spread and cover
the entire substrate (Fig. 1B), whereas the cells on TMV-coated
substrates aggregated to form nodule-like cell clumps (Fig. 1E).
After 24 hours of culture in basal media, the media were changed
to osteogenic media and the cells were imaged again 8 hours later.
The cells on TCP remained spread out with no aggregation
(Fig. 1C), and the cells on TMV substrates continued to form
larger aggregates (Fig. 1F).
Fig. 1 Diﬀerential interference contrast (DIC) images of BMSCs on
TCP and TMV substrates showing morphological changes over
culture time. The time points are (A, D) 6 hours and (B, E) 24 hours
after seeding in basal media, followed by (C, F) 8 hours in osteogenic
media. The cells on standard TCP are well spread (A–C), whereas the
cells on TMV coated substrates are often rounded and poorly spread
(D–F). Scale bar is 100 mm.
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Cell adhesion and spreading are highly dependent on the
substrate surface. Interestingly, in this study, the cell morphologies
were distinct as early as at 6 hour post seeding. The diﬀerence in
cell shapes observed indicates altered cellular responses. Gene and
protein analyses during the ﬁrst 24 hours of osteoinduction were
carried out to identify how TMV substrates could enhance
osteogenesis of BMSCs. In order to examine if TMV is capable
of chemically inducing the changes, the supplement of TMV into
culture media was included in all studies. It is important to note
that the morphology of BMSCs grown in media supplemented
with TMV remained the same as that of TCP control (data not
shown).
TMV on the surface alters BMP2 and IBSP gene expression
In the previous study, we found enhanced osteogenic diﬀer-
entiation of BMSCs when cultured on TMV coated APTES
glass coverslips.8 Without TMV coating, the APTES glass
coverslips showed similar eﬀects to uncoated glass and TCP.9
Microarray analysis of total cellular mRNA and real time
PCR results indicated that the BMP2 mRNA level was higher
in cells cultured on TMV coated substrates than in cells on
TCP.8 Based on these results, we examined the temporal
changes in gene expression involved in early diﬀerentiation
(ALPL, BMP2 and IBSP) of cells cultured on TMV coated
substrates, cells supplemented with TMV in solution, and cells
cultured on conventional TCP (Fig. 2). Although there was no
signiﬁcant diﬀerence in the alkaline phosphatase gene
(ALPL) mRNA expression for cells cultured on the three
diﬀerent substrates after 8 hours, the expression signiﬁcantly
increased after 24 hours in cells cultured on TMV substrates
(Fig. 2A). However, the increase only exhibits less than two-fold
diﬀerence over uninduced cells. Since alkaline phosphatase
(ALP) is an enzyme that facilitates matrix mineralization and
gradually increases over a period of 2 weeks,21 it is possible that
the time point of this study is too early to observe any
signiﬁcant upregulation in ALPL mRNA expression.
For cells cultured on TMV coated substrates, BMP2
expression levels were six-fold higher than uninduced cultures
after 8 hours of osteoinduction. In comparison, the cells in
traditional cultures had only slightly increased BMP2 gene
expression by two-fold (Fig. 2B). The initial increase in BMP2
gene expression for TCP had diminished back to the basal
level after 24 hours, whereas the cells cultured on TMV coated
substrates still maintained higher BMP2 gene expression
levels, a three-fold increase over TCP substrates (Fig. 2B).
Although the addition of TMV as a solution supplement to
the culture media resulted in a modest increase in BMP2
expression at 24 hours, it failed to provide the same eﬀects
as the virus-coated substrates. The initial results with TMV in
solution indicate that the coating of the virus to the solid
support is necessary to aﬀect early BMP2 gene expression and
the virus itself does not act as a soluble inducer. The results
also suggest that TMV coated substrates enhance osteogenic
diﬀerentiation of BMSCs by increasing BMP2 mRNA levels.
In addition to increased BMP2 gene expression, mRNA
levels for integrin-binding sialoprotein (IBSP), a secreted
extracellular matrix protein required for hydroxyapatite
formation, increased over time in both TCP and TMV samples.
IBSP is an osteogenic marker associated with mineralizing
tissues,22 hence the increase in IBSP gene expression within
24 hours is an important discovery in explaining the role of
TMV in osteogenic diﬀerentiation.8 IBSP gene expression
levels for cells grown on TMV were two-fold higher than
those on TCP after 8 hours of osteoinduction and the diﬀerence
further increased to ﬁve-fold after 24 hours (Fig. 2C). The
addition of TMV as a solution to the culture media did not
provide a similar increase in IBSP expression levels to TMV
coated substrates (Fig. 2C).
The apparent increase in BMP2 and IBSP mRNA levels
for the cells on TMV-coated substrates suggests that these
two proteins are involved in the enhancement of osteogenic
diﬀerentiation (Fig. 2B and C). The observed diﬀerences in
gene expression of BMP2 and IBSP indicate that the surface
coating with the virus moderates BMP2 and IBSP expression
levels within the ﬁrst day, and the virus itself does not act as a
soluble chemical inducer, but rather as a substrate with unique
topographical features, or oﬀer a rough surface, at both nanometre
Fig. 2 RT-qPCR analysis of osteospeciﬁc gene expression of BMSCs
under osteogenic conditions. For each growing condition, the proﬁles
showed two time points: 8 and 24 hours after induction with
osteogenic media. Gene expression in the cells seeded on TCP, TCP
with TMV in solution and TMV substrates under osteogenic condi-
tions. (A) ALPL expression was upregulated in cells grown on TMV at
24 hours. (B) BMP2 expression at both time points was signiﬁcantly
increased in cells grown on TMV substrates. (C) IBSP was highly
expressed in cells grown on TMV substrates at both time points. In all
graphs, the error bars denote 1 s.d. ** and * represent po 0.05 and
p o 0.1, respectively.
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and micrometre scales. Such surface features have been observed
withM13 bacteriophage and TMV to aﬀect cell directionality and
ECM protein deposition.20,23 It was demonstrated that nanoscale
topography (e.g. roughness) directly inﬂuences cell adhesion
leading to altered cellular behaviours including proliferation and
diﬀerentiation.3,24 The topographical features of TMV substrates
before and after incubation in media observed by atomic force
microscopy revealed such rough surfaces from the TMV coating,
which was still visible after 24 hours of cell culture (Fig. S1, ESIw).
TMV substrate induces higher localized BMP2 production
The increase in the BMP2 mRNA expression level was
corroborated by ELISA, showing a similar trend to BMP2
increase at 8 and 24 hours in osteogenic media (Fig. 3A). In
comparison to uninduced controls, the cells on TMV coated
substrates expressed four-fold and three-fold higher levels of
BMP2 at 8 and 24 hours, respectively. For TCP culture, there
was no signiﬁcant increase in BMP2 production at either time
point (Fig. 3A). Although the addition of TMV in solution
showed an increase in the BMP2 mRNA level after 24 hours
(Fig. 2B), the protein analysis did not validate this temporal
increase (Fig. 3A). Thus, among the three growth conditions,
only TMV coated surfaces induced a signiﬁcant increase in BMP2
mRNA and protein expression after 8 hours of osteogenic
induction.
Immunoﬂuorescence imaging of BMP2 revealed that the
morphogen is localized to the cell aggregates. As shown in
Fig. 3B, BMSCs on TMV stained positive for BMP2 with
higher ﬂuorescence intensity at both time points. BMP2 was
observed around the cells that formed nodules or aggregates.
It is hypothesized that too strong substrate binding may inhibit
osteogenic diﬀerentiation.25 Similar to the previous results, the cells
with TMV in solution stained poorly for BMP2 (data not shown).
The concentrations of secreted BMP2 in conditioned media
from the three culture conditions were measured by sandwich
based ELISA. Higher concentration of BMP2 was observed in
media with cells on TMV substrates, compared to cells on
TCP with and without TMV supplemented in the media. The
concentrations ranged between 100 and 200 pg mL1 (data not
shown), which is consistent with that reported in an ultrasound-
induced BMP2 secretion within 24 hours.26
Enhanced osteogenesis requires TMV coating on substrates
The enhancement in bone diﬀerentiation was also assessed by
measuring ALP activity and calcium deposition at day 7, 14,
and 21. ALP is an early marker of osteogenesis and its activity
mediates matrix mineralization. Although only minor upregu-
lation of ALPLmRNA levels was observed by RT-qPCR after
24 hours, ALP enzyme activity assays over the course of
3 weeks showed signiﬁcant diﬀerences at day 7 and 14 (Fig. 4A).
Similar to the earlier results, the addition of TMV in solution does
not increase ALP activity, and only the cells on TMV coated
substrates had signiﬁcantly higher enzyme activities compared to
controls. The enzyme activity at day 21 diminishes to the same level
for all samples, suggesting that the observed level may be a basal
activity level of ALP during the mineralization stage.
Calcium deposition was determined at day 14 by staining
with Alizarin Red S. Small nodules of mineralized calcium
were observed for controls and cells supplemented with TMV
in solution, whereas the nodules were visibly larger for the cells
on TMV-coated substrates (Fig. 4B). UV-Vis absorbance
measurements of the extracted dyes indicated that the cells
on TMV substrates had double content of calcium compared
to controls (Fig. 4C). The addition of TMV solution does not
enhance matrix mineralization. These results conﬁrm our
hypothesis that TMV provides a topographical cue to enhance
osteogenic diﬀerentiation, likely by changing the surface
roughness. The combined results from RT-qPCR, ELISA
and immunostaining clearly indicate that BMP2 expression
was signiﬁcantly induced within 24 hours of induction with a
peak expression level at 8 hours. The enhancement requires the
virus as a substrate rather than as a solution supplement,
suggesting the role of topography or surface roughness in
TMV-mediated osteogenesis.
Additive eﬀect on BMP2 gene expression
The osteogenic inducing agents that are routinely used for
in vitro cultures include b-glycerolphosphate, ascorbic acid,
and functions dexamethasone. Individual inducers facilitate
diﬀerence in the bone diﬀerentiation process.21 To examine
Fig. 3 Diﬀerential expression and localization of BMP2 analyzed by
ELISA and immunohistochemical staining. (A) Quantiﬁcation of
BMP2 protein expression at 8 and 24 hours normalized to the cell
number by ELISA. The values are expressed as fold change compared
to cells on TCP before osteoinduction. The error bars denote 1 s.d.
** p o 0.05 based on ANOVA. (B) Cells on TCP control or TMV
substrates were collected at 8 and 24 hours after osteogenic induction.
At both time points, cells on TMV-coated surfaces expressed more
BMP2 protein and the protein is highly expressed at cell aggregates.
Color representation: nucleus (blue), BMP2 (green), actin (red). Scale
bar is 100 mm.
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which osteogenic inducers are required to induce BMP2
upregulation in BMSCs grown on TMV substrates, the
inducers were individually added to diﬀerent cell cultures
and cells were analyzed after 8 hours. Within this time frame,
BMP2 expression levels were the same for cells grown on TCP
with or without the three osteogenic inducers (Fig. S2, ESIw).
The BMP2 expression level partially increased for cells grown
on TMV coated substrates without any inducers. While the
addition of b-glycerolphosphate or L-ascorbic acid 2-phosphate did
not upregulate the BMP2mRNA level, dexamethasone resulted in
a signiﬁcant increase in the BMP2 expression level after 8 hours of
osteogenic induction (Fig. 5). b-Glycerolphosphate is a phosphate
donor for matrix mineralization and in turn increases alkaline
phosphatase activity. L-Ascorbic acid 2-phosphate, a stable form of
vitamin C, is a source for collagen synthesis which is a major
component of bone ECM. However, there is no evidence on the
direct eﬀect of these two compounds on modulating BMP2
production. On the other hand, dexamethasone, a glucocorticoid
derivative, induced a signiﬁcant increase in the BMP2 expression
level in BMSCs on TMV substrates. Bi et al.27 illustrated that
the treatment of dexamethasone induced BMP2 expression in
BMSCs, resulting in a gradual increase of ALP activity over
the ﬁrst 2 weeks. However, the enhanced eﬀect of dexamethasone
on BMP2 expression due to surface roughness has not been
reported before. This observed enhancement of BMP2 expression
from dexamethasone alone is similar to that when all three
osteogenic inducers were added to the culture media of cells on
TMV wafers (Fig. 5). Although there is a chance that TMV could
act as a carrier for dexamethasone internalization, the fact that
TMV supplemented media did not enhance BMP2 expression and
osteogenesis eliminates this possibility. This clearly highlights the
ability of TMV nanosurfaces in the presence of dexamethasone to
promote osteogenesis.
To determine if the TMV coating concentrates and immobilizes
the chemical inducers to the surface, Quartz CrystalMicrobalance
with Dissipation (QCM-D) was used to monitor the deposition of
each inducer on a TMV-coated substrate. As shown in Fig. S3
(ESIw), there is no signiﬁcant shift in the resonance frequency of
the electrode, which indicates no measurable surface deposition of
the osteogenic inducers. While eﬀects of dexamethasone and
TMV-coating appear to converge on early BMP2 expression,
the initial assessment with QCM-D and the previous
TMV solution supplement studies suggest that TMV and
dexamethasone do not interact with each other (Fig. S3,
ESIw). Furthermore, the virus-coating alone appeared to
aﬀect BMP2 expression, which suggests that an alternative
regulatory mechanism may be involved.
TMV coating alters cytokine expression
Several other cytokines apart from BMP2 regulate bone
remodelling.28–30 Speciﬁcally, inﬂammatory cytokines from
T-cell conditioned media, including TNF-a, IFN-g, IL-1,
IL-17, were shown to induce BMP2 expression.31 In another
study, IL-6, IL-8, monocyte chemotactic protein 1 (MCP-1),
macrophage inﬂammatory protein 1 alpha (MIP-1a), MIP-3a
Fig. 4 Cytochemical analysis of the bone diﬀerentiation process of
BMSCs on TCP, TCP with TMV in media, TMV substrates at 7, 14,
and 21 days after osteogenic induction. (A) Alkaline phosphatase
activity of cells under three diﬀerent conditions. Cells on TMV
substrates have an increase in enzyme activity at day 7 and 14, whereas
the addition of TMV solution does not alter the enzyme activity when
compared to control. Alkaline phosphatase activity drops to baseline at
day 21 for all conditions. (B) Alizarin red staining of each sample at day
14. (C) Absorbance at 548 nm normalized to the cell number to indicate
a relative amount of calcium deposit at day 14 stained by alizarin red
solution. The mineralization of cells on TMV substrates doubles that of
TCP and TMV in solution, suggesting an improvement in osteogenesis
(**p o 0.05 based ANOVA). The error bars denote s.d.
Fig. 5 RT-qPCR analysis of BMP2 expression in the cells seeded on
TCP control and TMV substrates in individual osteogenic inducers for
8 hours. The osteogenic inducers are sodium b-glycerolphosphate,
L-ascorbic acid 2-phosphate and dexamethasone. The addition of all
three inducing agents resulted in the highest level of BMP2 mRNA.
The error bars denote s.d. and ** represents p o 0.05.
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were shown to be involved in ﬁbroblast growth factor-2
(FGF2) mediated osteogenesis.30 There is also an evidence
that the addition of chemokine (C–X–C motif) ligand (CXCL)
12 enhanced BMP2-induced diﬀerentiation.32 We therefore
investigated the cells’ response to the virus by screening such
cytokines or other relevant growth factors which could aﬀect
early bone diﬀerentiation. Cytokine antibody arrays for 29
cytokines were used to screen the conditioned media from cells
cultured on TCP and TMV coated wafers. The media consist-
ing of primary media only was collected after 24 hours of
culture and examined. Tissue inhibitor of metalloproteinases-1
(TIMP-1) was the only molecule secreted from both culture
conditions, while cytokine-induced neutrophil chemoattractant
1 (CINC-1), CINC-2, MIP-3a, and vascular endothelial growth
factor (VEGF) were detected from the conditioned media for
the cells on TMV wafers (Fig. 6). According to Kim et al.,30
CINC-1 and MIP-3a recruit neutrophils and monocytes to
induce osteogenesis. However, the previous studies did not
correlate these cytokines with enhanced BMP2 upregulation
during osteogenesis. Future studies on the osteogenic eﬀects
of these individual cytokines may reveal their involvement
in BMP2-mediated bone diﬀerentiation. It could possibly lead
to a discovery of new biomaterials to elicit these cytokine
productions in order to improve bone healing.
The remaining 24 cytokines, CINC-3, ciliary neurotrophic
factor (CNTF), fractalkine, GM-CSF, sICAM-1, IFN-g,
IL-1a, -1b, -1ra, -2, -3, -4, -6, -10, -13, -17, IP-10, lipopoly-
saccharide induced C–X–C chemokine (LIX), L-selectin,
monokine induced by gamma interferon (MIG), MIP-1a,
RANTES, thymus chemokine and TNF-a were below the
detection limits of the cytokine array.
Actin depolymerization for cells on TMV substrates
Since there was no established direct correlation of other
cytokines and osteogenesis, cell morphologies were closely
observed prior to osteoinduction. It was demonstrated that
BMP2 production was highly localized around the cell nodules
(Fig. 3B). Some reports illustrated that culture materials
modulate bone diﬀerentiation through cytoskeleton organization.33
The investigation of actin polymerization and organization was
carried out to compare cells on TCP and TMV substrates prior to
osteoinduction, at which time cell aggregation was ﬁrst observed.
The actin intensity by phalloidin staining was more intense in
cells on TMV substrates, indicating higher activity from actin
polymerization which could facilitate mobilization of cells to
form nodules within 24 hours of cell seeding (Fig. 7). At higher
magniﬁcation, cells on TCP surfaces maintained highly
aligned sarcomeric striations, whereas cells on TMV substrates
displayed nonaligned striations. These observations are similar
to those obtained from an experiment by Mendonc¸a et al.,25
which demonstrated that cells on a rougher surface topography
exhibit an undeﬁned long axis with thicker actin ﬁlaments
leading to less initial cell spreading followed by enhanced
mineralization.
Reduced focal adhesion size
The interaction between cell and ECM is mediated by cell
surface receptors (i.e. integrins).34 Vinculins, part of focal
adhesion complexes (FACs), couple the integrins to the cyto-
skeleton allowing crosstalk between ECM and intracellular
signalling.35 Biggs et al. highlighted the eﬀects of nanogrooves
mediating osteoblastic functions by regulating focal adhesions
and subsequent intracellular molecular events.3 There are
other reports showing that integrin-mediated focal adhesion
is an important regulator for osteogenesis.36 Previous studies
illustrated that increased localization of vinculin is associated
with larger focal adhesion (FA) size and strengthening of
adhesion leading to reduced cell motility.35,37 Smaller size of
FAs suggests that BMSCs attached to TMV substrates weakly,
whereas larger size of FACs dictates stronger cell–substrate
adhesion.38 While BMSCs on standard TCP exhibited larger
Fig. 6 Comparison of cytokine proﬁles in culture media of BMSCs
on TCP control and TMV substrates for 24 hours, prior to osteo-
induction. An antibody array containing 29 diﬀerent cytokines was used
to compare protein proﬁles produced by cells on diﬀerent substrates.
TIMP-1 was detected in both cultures with higher levels from TMV
substrates. However, the productions of some cytokines and growth
factors were induced only by TMV-coated wafer, including CINC-1,
CINC-2, MIP-3a, and VEGF.
Fig. 7 Cytoskeleton immunochemical staining showing actin
polymerization and organization of cells on TCP control and TMV
substrates after 24 hours seeding, prior to osteoinduction, at low- (top
row) and high-magniﬁcation (bottom row). Similar ﬁbrous cytoskeleton
organization was observed where cells spread out in both cell cultures.
However, in cell aggregates on TMV substrates the actin intensity was
higher (white circles) and well-deﬁned actin ﬁlament was absent (white
arrow). Color representation: nucleus (blue), actin (red). Scale bars are
200 mm for top row and 25 mm for bottom row.
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average vinculin size, indicating stronger adhesion to the
underlying substrate, the cells on TMV substrates showed
smaller FA sizes (Fig. 8A and B). The signiﬁcantly smaller
FA size for cells on TMV substrates is likely to increase cell
motility and facilitate the formation of cell aggregates within
24 hours of seeding. Further studies are necessary to establish
the correlation of the focal adhesion of BMSCs on virus-
coated substrates with the downstream responses.
Experimental
TMV isolation
TMV was isolated and puriﬁed according to a protocol
previously reported.8,10
Preparation of TMV coated substrates
For imaging experiments, 22  22 cm glass coverslips (VWR)
were cleaned by piranha solution (7 : 3 mixture of 98% H2SO4
and 30% H2O2) at 75 1C for 2 hours, followed by three washes
with water (Millipore Synergy UV system, 18.2 MO) and
sonication. The dry glass coverslips were immersed in 1%
(v/v) of 3-aminopropyltriethoxysilane (APTES) in ethanol for
10 minutes and washed thoroughly with ethanol to remove
excess APTES. After drying with nitrogen, APTES coating
was crosslinked at 160 1C in a vacuum oven for 1 hour. The
wafers were dried and ﬂushed with nitrogen gas for complete
drying. For gene expression experiments, APTES coated slides
(Lab Scientiﬁc Inc.) were cut into 1.5 cm2 wafers. Both
coverslips and slide wafers were sterilized with ethanol before
use. For TMV coating, the wafers and coverslips were coated
with 0.2 mg mL1 TMV solution diluted in water and the
coated substrates were dried overnight in a sterile biosafety
cabinet. The virus coverage on the wafers was characterized
using tapping-mode AFM images using a NanoScope IIIA
MultiMode AFM (Veeco). Si tips with a resonance frequency
of approximately 300 kHz, a spring constant of about 40 Nm1
and a scan rate of 0.5 Hz were used.
BMSC isolation and expansion
Primary BMSCs were isolated from the bone marrow of
young adult 80 g male Wister rats (Harlan Sprague Dawley,
Inc.). The procedures were performed in accordance with the
guidelines for animal experimentation by the Institutional
Animal Care and Use Committee, School of Medicine, University
of South Carolina. Cells were maintained in growth medium
(DMEM supplemented with 10% fetal bovine serum (FBS),
penicillin (100 U mL1), streptomycin (100 mg mL1) and
amphotericin B (250 ng mL1)) and passaged no more than
four times after isolation. To induce osteogenesis, growth
media were replaced with osteogenic media consisting of
DMEM supplemented with 10% FBS, penicillin (100 U mL1),
streptomycin (100 mg mL1), amphotericin B (250 ng mL1),
10 mM sodium b-glycerolphosphate, L-ascorbic acid 2-phosphate
(50 mg mL1) and 108 M dexamethasone. Media were
replenished every 3–4 days.
Quantitative real-time RT-PCR analysis (RT-qPCR)
TMV coated wafers were seeded with 4.5  104 cells per wafer
and allowed to attach overnight in growth media. The media
are replaced with osteogenic media and cultured for 8 and
24 hours. In addition, BMSCs with similar density were seeded
on 3.8 cm2 tissue culture plastic (TCP), with or without TMV
in the osteogenic media, for the abovementioned time periods.
Furthermore, to determine which osteogenic components are
required to enhance osteogenesis on TMV-coated wafers,
BMSCs on TMV substrates were cultured in basal media with
each osteogenic inducing agent for 8 hours. The cell cultures were
terminated at this time point and total RNA was subsequently
extracted using an RNeasy mini puriﬁcation kit, Qiagen. The
number of samples for each experiment (n) was two and each
experiment was repeated (N) three times.
The quality and quantity of the extracted RNA were
analyzed using Bio-Rad Experion (Bio-Rad Laboratories)
and were reverse transcribed by using qScriptt cDNA Supermix
(Quanta Biosciences). RT-qPCR (iQ5 real-time PCR detection
system Bio-Rad Laboratories) was done by the method described
Fig. 8 Immunochemical staining showing the diﬀerence in vinculin size of cells on TCP control or TMV substrates for 24 hours.
(A) Immunoﬂuorescence images of cells on diﬀerent substrates for 24 hours prior to osteoinduction (top panel). Color representation: nucleus
(blue), vinculin (green), phalloidin (red). The bottom panel illustrates vinculin masking and selection for size analysis. The selected vinculin spots as
part of the focal adhesion complex are highlighted in blue. (B) Average vinculin size of cells on either TCP or TMV-coated surface. The error bars
denote s.d. and *p o 0.05 based on equal variance two-tailed Student’s t-test.
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as: 60 cycles of PCR (95 1C for 20 s, 58 1C for 15 s, and 72 1C for
15 s), after initial denaturation step of 5 minutes at 95 1C, by
using 12.5 mL of iQ5 SYBR Green I Supermix, 2 pmol mL1 of
each forward and reverse primers and 0.5 mL cDNA templates
in a ﬁnal reaction volume of 25 mL. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as the housekeeping gene.
Data collection was enabled at 72 1C in each cycle and CT
(threshold cycle) values were calculated using the iQ5 optical
system software version 2.1. The expression levels of diﬀeren-
tiated genes and undiﬀerentiated genes were calculated using
Pfaﬄ’s method (M. W. Pfaﬄ, G. W. Horgan and L. Dempﬂe,
Relative expression software tool) for group-wise comparison
and statistical analysis of relative expression results in real-time
PCR, using GAPDH as the reference gene. Quantiﬁcation of
gene expression was based on the CT value of each sample
which was calculated as the average of three replicate measure-
ments for each sample analyzed. The fold change of each gene
expression level is normalized to BMSCs before seeding on
diﬀerent substrates. ‘‘Pair Wise Fixed Reallocation Randomiza-
tion Test’’ was performed on each sample and a value of
p o 0.05 was regarded as signiﬁcant. The primers used for
RT-qPCR are shown in Fig. S4 (ESIw). The primers were
synthesized commercially (Integrated DNA Technologies,
Inc.), and evaluated at an annealing temperature of 58 1C.
Cytochemical staining and quantiﬁcation
For cytochemical staining, 4.5  104 cells were seeded on TMV
coated wafers and allowed to attach overnight in basal media.
The media were replaced after 24 hours of culture with osteogenic
media and cultured for additional 7, 14, and 21 days. As controls,
BMSCs were seeded on 3.8 cm2 TCP at similar densities for the
same time periods. CellTiter Blues assay (Promega) was used to
determine the number of cells in each sample one hour prior to
cell ﬁxation. The cells were ﬁxed with 4% paraformaldehyde for
15minutes at room temperature. To determine ALP activity, each
ﬁxed sample was incubated in 500 mL of 1-Step p-nitrophenyl
phosphate solution (Thermo Scientiﬁc) for 15 minutes at room
temperature. Then the solution was transferred to a new micro-
fuge tube with 250 mL of 2 N NaOH to stop the reaction and the
absorbance at 405 nm was measured. The number of samples for
each experiment (n) was three and each experiment was repeated
(N) two times.
To compare calcium deposition, ﬁxed samples at day 14
were stained with 0.1% Alizarin red solution (Sigma-Aldrich)
pH 4.1–4.5 for 30 minutes. Since the reaction was highly light
sensitive, the substrates were wrapped in aluminium foil
during the Alizarin red staining. After washing with ultrapure
water, 200 mL of 0.1 N NaOH was added to each sample to
extract the dye from the sample. The amount of dye was
quantiﬁed by measuring the absorbance at 548 nm wave-
length. Both absorbance values at 405 nm and 548 nm were
normalized against the cell number from CellTiter Blues
standard curve. The number of samples for each experiment
(n) was three and each experiment was repeated (N) two times.
Enzyme-linked immunosorbent assay (ELISA)
In order to validate RT-qPCR gene expression at the protein
expression level, TMV coated coverslips and uncoated coverslips
were seeded with 1.0  105 cells per piece. 40 mg of TMV was
added to each TMV-in-solution culture. The cultures were
terminated at 8 and 24 hours after osteoinduction. CellTiter Blues
(Promega) was used to determine the cell number in each sample
one hour prior to cell ﬁxation with 4% paraformaldehyde. Each of
the samples was then permeabilized with 0.1% Triton-X 100 for
15 minutes and blocked in 1.5% bovine serum albumin (BSA,
Sigma-Aldrich) in PBS for 1 hour at room temperature. After
blocking, the cells were incubated overnight with mouse mono-
clonal antibody targeting BMP2 (R&D systems) at 1 : 100 dilution
in blocking buﬀer. Secondary goat anti-mouse antibody conju-
gated with horseradish peroxidase (Cayman Chemical) was used
at 1 : 1000 dilution for 2 hours at room temperature. After
washing, 1 mL of 3,30,5,50-tetramethylbenzidine (TMB) solution
prepared from TMB ready-to-use tablet (Amresco) was added to
each sample, incubating on a rocker for 30 minutes at room
temperature. The reaction was stopped by adding 500 mL of 2.0M
H2SO4. Absorbance at 450 nmwavelength wasmeasured and then
normalized against the cell number. Protein expressions are shown
as fold change relative to cells cultured on TCP without osteoin-
duction. The number of samples for each experiment (n) was three
and each experiment was repeated (N) two times.
Immunoﬂuorescence assays and image analysis
The localization of endogenously expressed BMP2 was examined
by immunohistochemical staining. TMV coated coverslips and
uncoated coverslips were seeded with 1.0 105 cells per piece. The
cultures were terminated at 8 and 24 hours after osteoinduction.
Cells were ﬁxed in 4% paraformaldehyde at room temperature for
30 minutes. Each of the samples was then permeabilized with
0.1% Triton-X 100 for 15 minutes and blocked in 1.5% bovine
serum albumin (BSA, Sigma-Aldrich) in PBS for 1 hour at room
temperature. After blocking, the cells were incubated overnight
with mouse monoclonal antibody targeting BMP2 (R&D Systems)
at 1 : 100 dilution in blocking buﬀer. Secondary goat anti-mouse
antibody conjugated with ﬂuorescein (Chemicon) was used at
1 : 100 dilution for 2 hours at room temperature. Rhodamine–
phalloidin (1 : 100 in PBS) was used to stain ﬁlamentous actin.
Nuclei were stained with DAPI (4,6-diamidino-2-phenylindole,
100 ng mL1). The samples were then mounted and sealed with
clear nail polish before imaging. Images of the stained substrates
were taken on an Olympus IX81 ﬂuorescent microscope.
For imaging of actin structure and focal adhesion associated
protein, vinculin, uncoated coverslips and TMV coated coverslips
were seeded with 1.0  105 cells each. Cultures were terminated
24 hours after seeding in basal media. The samples were ﬁxed,
permeabilized, and blocked as described above. Cells were incu-
bated with anti-vinculin mouse monoclonal antibody (Neomarkers)
at 1 :200 dilution in blocking buﬀer. Secondary goat anti-mouse
antibody conjugated with ﬂuorescein (Chemicon) was used at
1 :100 dilutions for 2 hours at room temperature. Rhodamine–
phalloidin (1 :100 in PBS) was used to stain actin. Nuclei were
stained with DAPI, and the samples were mounted and sealed with
clear nail polish before imaging.
SlideBookt 5 was used to select and analyze immunoﬂuores-
cence images of vinculin. After setting the threshold for masks,
the criteria used to select vinculin spots to be analyzed were XY
shape factor larger than 1.5 and area size between 0.5–15 mm.
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The average size of vinculin for each image was calculated,
followed by the calculation of average vinculin size of cells on
TCP and TMV substrates and the standard deviation from
average values of three individual images.
Statistics/data analysis
Data were expressed as mean  standard deviation (s.d.) of
the measured values for cytochemical staining quantiﬁcation
and ELISA. Data were analysed by ANOVA for multiple
comparisons, and a post hoc test for group to group comparisons,
with p o 0.05 considered statistically signiﬁcant.
Cytokine array
Rat Cytokine Antibody Array (R&D Systems) was used
according to the manufacturer’s instructions. Culture media
were collected at 24 hours after cell seeding on TCP control
and TMV-coated glass. Brieﬂy, membranes were blocked for
1 hour followed by overnight incubation at 4 1C in 1 mL
of cell culture media pre-incubated with provided detection
antibody cocktail. After washing, the membranes were incu-
bated with horseradish peroxidase-conjugated streptavidin for
30 minutes. Signals were developed with a Pierce ECLWestern
Blotting Substrate (Thermo Scientiﬁc) and detected onCL-XPosure
Film (Thermo Scientiﬁc).
Conclusions
Early morphological diﬀerences were documented for cells
seeded on TMV-coated substrates, wherein the cells often
aggregated and spread poorly. The highest BMP2 mRNA
and protein levels were detected in cells cultured on TMV-coated
substrates after 8 hours of osteoinduction and maintained high
BMP2 mRNA and protein levels even after 24 hours. To
eliminate the possibility that the virus may act as a soluble
inducer, the virus was supplemented in the media as a solution,
however this approach did not aﬀord the same enhancement
as the immobilized virus substrate. BMP2 was localized to the
cell aggregates, which are only present on cells cultured on
TMV coated substrates. Decoupling the three osteogenic
agents (dexamethasone, b-glycerophosphate, ascorbic acid) suggests
that TMV coating enhances the eﬀect of dexamethasone, but TMV
coating alone was suﬃcient to induce BMP2 gene expression.
Screening the media for cytokines revealed the presence of
CINC-1, CINC-2, MIP-3a, and VEGF. The surface topography
from TMV coating disrupted actin alignment and reduced FA size.
The smaller FA indicates a weaker cell–substrate interaction
on TMV substrates. The results suggest that a TMV substrate
promotes cell aggregation and induces an early onset BMP2
expression.
Although extensive studies with BMP2 show potent osteo-
inductive eﬀects at early time points, additional studies involving
BMP2 knockdown by siRNA and noggin will be necessary to
eliminate other possible factors involved in TMV-mediated
osteogenesis. Further investigation into other early cell-material
and secreted protein–material interactions is necessary for a better
understanding of how the TMV coating can promote the endo-
genous production of BMP2. The regulation of endogenous BMP2
expression will be critical for advanced biomaterial development in
bone tissue engineering applications.
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